News

Northern 3 VCT PLC Boosts Share Value with Recent Buyback

Northern 3 VCT PLC Boosts Share Value with Recent Buyback

Northern 3 VCT PLC's Recent Share Purchase Announcement

Northern 3 VCT PLC is engaging with shareholders by announcing an important transaction regarding their ownership. The Company revealed its decision to purchase a total of 638,469 ordinary shares of 5p each for cancellation on 26 September 2025. This strategic move has been executed under an authority granted by the shareholders and demonstrates the Company’s commitment to enhancing shareholder value.

Details of the Share Buyback

The shares were acquired at a price of 83.79p per share, indicating a notable investment in their own stock. This purchase represents about 0.43% of the Company’s total issued ordinary share capital. After this transaction, the total number of ordinary shares remaining in circulation stands at 147,737,417.

Understanding the Share Structure

According to the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Northern 3 VCT PLC's equity consists solely of ordinary shares, each with a nominal value of 5p. Importantly, all these shares carry voting rights, giving shareholders a voice in the company's direction. At this time, the Company does not hold any shares in treasury, meaning all issued shares are available for trading and ownership.

Importance of Voting Rights and Transparency

With the total voting rights in the Company being 147,737,417, shareholders can utilize this figure to determine their voting interest in the Company and any fluctuations in that regard. Such transparency is crucial as it grants the shareholders the knowledge needed to make informed decisions about their investments and to comply with any notification requirements laid out by the DTRs.

Long-Term Shareholder Value

This recent buyback reflects Northern 3 VCT PLC’s determination to actively manage their capital structure and potentially increase their stock’s attractiveness to investors. By reducing the number of shares in circulation, the Company not only aims to improve earnings per share but also to signify a strong belief in its future prospects, which can instill confidence among current and prospective shareholders.

Company Contacts for More Information

For those interested in further details about this buyback or the Company’s strategic direction, Sarah Williams and James Sly from Mercia Fund Management Limited are available for inquiries at 0330 223 1430. They can provide additional insights regarding what this transaction might mean for the shareholders moving forward.

Frequently Asked Questions

What is Northern 3 VCT PLC's recent share transaction?

Northern 3 VCT PLC purchased 638,469 ordinary shares for cancellation at a price of 83.79p each, representing 0.43% of its issued share capital.

What is the current number of shares in Northern 3 VCT PLC?

As of the latest transaction, there are 147,737,417 ordinary shares remaining in circulation.

How does this share buyback affect shareholders?

The share buyback can enhance shareholder value by increasing earnings per share and reducing the total number of shares outstanding.

Who can shareholders contact for more information?

Shareholders can reach out to Sarah Williams or James Sly at Mercia Fund Management Limited at 0330 223 1430 for any queries related to the transaction.

What are voting rights in the context of this announcement?

All ordinary shares have voting rights, allowing shareholders to participate in corporate decisions, and the total voting rights are currently 147,737,417.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence: The 2025 Audio Description Awards Gala

Updated Category News Views 181

Join the Celebration at the 2025 Audio Description Awards Gala The American Council of the Blind (ACB) warmly invites everyone to participate in the highly anticipated 5th Annual Audio Description Awards Gala. Set to take place in November 2025, this event promises to be a dazzling showcase of talent, creativity, and inclusivity within the media landscape. With a focus on...

Continue Reading
The Alkaline Water Company Expands Its Reach in the Midwest

Updated Category News Views 177

The Alkaline Water Company's Growth in the Midwest Market The Alkaline Water Company, Inc. (OTC: WTER), a prominent name in the beverage industry, is making waves with its latest expansion efforts. With a focus on providing high-quality purified alkaline water enhanced with Himalayan rock salt, the company has recently partnered with Pete's Market, a well-respected...

Continue Reading
SELLAS Life Sciences Doses First Pediatric AML Patient in Trial

Updated Category News Views 177

SELLAS Life Sciences Takes a Major Step in Pediatric AML Treatment SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) has reached a significant milestone by dosing the first pediatric patient in their ongoing Phase 2 trial of SLS009, a groundbreaking treatment aimed at relapsed/refractory acute myeloid leukemia (r/r AML). This development marks a notable advancement in their...

Continue Reading
Almara Women's Health Revolutionizes Care for Women Everywhere

Updated Category News Views 407

Almara Women's Health Launches Innovative Whole-Woman Care Uniting Seven Twin Cities Practices Under One Vision Almara Women's Health is introducing a groundbreaking model of care specifically designed for women of all ages. This newly unified collaboration of healthcare providers is set to transform the way women experience healthcare, ensuring that all aspects of their...

Continue Reading
Exploring the Growing Influence of Marketing Platforms Today

Updated Category News Views 115

The Surge of Influencer Marketing Platforms The global influencer marketing platform market is on a significant upward trajectory. This dynamic industry is projected to expand from USD 10.6 billion in 2023 to USD 14.2 billion in just one year, ultimately reaching a colossal USD 50.3 billion by 2028. Such extraordinary growth indicates a CAGR of 37.1% from 2024 to 2028....

Continue Reading